Digital Pathology Market Worth $1.86 Billion by 2030
                      Digital Pathology Market 
Worth $1.86 Billion by 
2030
Digital Pathology Market 2023-2030
Meticulous  Research®—a  leading  global  market  research  company,  published  a
research report titled ‘Digital Pathology Market by Offering (Hardware [Scanner,
Tissue Microarray], Software [Information Management, Image Analysis],
Service),  Application  (Diagnostic,  Drug  Discovery,  Training],  End  User
[Hospitals, Academic Institutes) - Global Forecast to 2030.’
Download sample Report Here:  https://www.meticulousresearch.com/download-
sample-report/cp_id=5433
According to this latest publication from Meticulous Research®, the digital pathology
market is projected to reach $1.86 billion by 2030, at a CAGR of 8.7% during the
forecast period. The growth of this market is attributed to the high prevalence of
cancer,  the increasing availability  of biomarkers and research on biomarkers, the
growing number of clinical trials for oncology drugs, the rising demand for accurate
detection  of  genetic  and rare  diseases,  and the  high  adoption  of  teleconsulting.
Furthermore, growing interests in precision medicine and emerging economies are
expected to offer significant opportunities for the market’s growth.
Digital Pathology Market: Future Outlook
The digital pathology market is segmented by Offering (Hardware [Tissue Microarray,
Scanners,  Other  Hardware],  Software,  Services),  Application  (Disease  Diagnosis,
Drug Discovery & Development, Education and Training, Teleconsultation), End User
(Hospitals  &  Clinics,  Diagnostic  Laboratories,  Research  Institutes  &  Academics,
Pharmaceutical  &  Biotechnology  Companies),  and  Geography.  The  study  also
evaluates industry competitors and analyzes the market at the regional and country
levels.
Based on offering, in 2023, the hardware segment is expected to account for the
largest share of the digital pathology market. The large market share of this segment
is  attributed to the high burden of  chronic diseases globally,  the rising need for
precise  diagnosis  and  personalized  care  pathways,  and  the  transformation  of
pathology  into  a  digital  discipline  is  increasing  the  demand  for  the  associated
hardware.
Based  on  application, the  digital  pathology  market  is  segmented  into  disease
diagnosis, drug discovery & development, education & training, and teleconsultation.
In 2023, the disease diagnosis segment is expected to account for the largest share
of the digital pathology market. The large market share of this segment is attributed
to the rising geriatric population, the high prevalence of chronic diseases, and the
increased adoption of teleconsulting due to the outbreak of the COVID-19 pandemic.
Based on end user, in 2023, the hospitals & clinics segment is expected to account
for the largest share of the digital pathology market. The large market share of this
segment  is  attributed  to  the  large  number  of  hospitals  &  clinics  globally,  the
increased need for digital pathology due to the high demand for pathological tests
coupled with the declining number of pathologists, and ongoing research in precision
medicine.
Speak  to  analyst:  https://www.meticulousresearch.com/speak-to-
analyst/cp_id=5433
This  research  report  analyzes  major  geographies  and  provides  a  comprehensive
analysis of the digital pathology market in North America (U.S. and Canada), Europe
(Germany, France, U.K., Italy, Spain, and Rest of Europe), Asia-Pacific (China, Japan,
India,  and  Rest  of  Asia-Pacific),  Latin  America  (Brazil,  Mexico,  and  Rest  of  Latin
America), and the Middle East & Africa.
Based  on  geography, in  2023,  North  America  is  expected  to  account  for  the
largest share of the digital pathology market, followed by Europe and Asia-Pacific.
Furthermore, in 2023, the U.S. is expected to be the largest shareholding market in
North  America.  The  market  growth  in  the  U.S.  is  driven  by  the  digitization  of
© Meticulous Research| [email protected] Page 1 of 5
Digital Pathology Market 2023-2030
pathology  services,  high  investments  in  R&D,  high  adoption  of  advanced
technologies,  and  the  increased  demand  for  reliable  and  faster  diagnostics.
Key Players:
The  key  players  operating  in  the  digital  pathology  market  are  3DHISTECH  Ltd.
(Hungary),  Leica  Microsystems  (a  subsidiary  of  Danaher  Corporation)  (Germany),
Hamamatsu  Photonics  K.K.  (Japan),  Nikon  Corporation  (Japan),  Visiopharm  A/S
(Denmark),  Koninklijke  Philips  N.V.  (Netherlands),  F.  Hoffmann-La  Roche  Ltd
(Switzerland), Glencoe Software, Inc. (U.S.), XIFIN, Inc. (U.S.), and PerkinElmer Inc.
(U.S.).
Quick to Buy: https://www.meticulousresearch.com/Checkout/65070255
Key questions answered in the report:
 Which are the high-growth market segments in terms of offering, application,
end user, and region/country?
 What was the historical market for digital pathology across the globe?
 What are the market forecasts and estimates for the period 2023–2030?
 What are the major drivers, restraints, challenges, opportunities, and trends in
the global digital pathology market?
 Who are the major players in the digital pathology market?
 How is  the competitive landscape, and who are the market leaders in the
global digital pathology market?
 What are the recent developments in the digital pathology market?
 What are the different strategies adopted by the major players in the digital
pathology market?
 What are the geographical trends and high growth regions/countries?
         Contact Us:
       Meticulous Research®
        Email- [email protected]
       Contact Sales- +1-646-781-8004
       Connect with us on 
LinkedIn- https://www.linkedin.com/company/meticulous-research
© Meticulous Research| [email protected] Page 2 of 5
Digital Pathology Market 2023-2030
© Meticulous Research| [email protected] Page 3 of 5